Bank Of America Corp Immutep LTD Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Immutep LTD stock. As of the latest transaction made, Bank Of America Corp holds 2,220 shares of IMMP stock, worth $4,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,220

Previous 2,518 11.83%

Holding current value

$4,218

Previous $5,000 20.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.82 - $2.36 $542 - $703	-298 Reduced 11.83%	2,220 $4,000
Q3 2024 Nov 14, 2024	BUY	$1.77 - $2.64 $499 - $744	282 Added 12.61%	2,518 $5,000
Q2 2024 Aug 14, 2024	BUY	$1.87 - $3.23 $2,726 - $4,709	1,458 Added 187.4%	2,236 $4,000
Q1 2024 May 15, 2024	BUY	$2.11 - $2.89 $1,637 - $2,242	776 Added 38800.0%	778 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.54 - $2.62 $7,778 - $13,233	-5,051 Reduced 99.96%	2 $0
Q1 2023 May 12, 2023	BUY	$1.63 - $2.06 $4,052 - $5,121	2,486 Added 96.84%	5,053 $8,000
Q4 2022 Feb 10, 2023	SELL	$1.6 - $2.53 $12,523 - $19,802	-7,827 Reduced 75.3%	2,567 $4,000
Q3 2022 Nov 14, 2022	SELL	$1.56 - $2.29 $3,717 - $5,457	-2,383 Reduced 18.65%	10,394 $16,000
Q2 2022 Aug 12, 2022	SELL	$1.96 - $3.09 $36,481 - $57,514	-18,613 Reduced 59.3%	12,777 $25,000
Q1 2022 May 16, 2022	BUY	$2.3 - $3.61 $50,008 - $78,492	21,743 Added 225.39%	31,390 $86,000
Q4 2021 Feb 08, 2022	BUY	$3.09 - $4.81 $58 - $91	19 Added 0.2%	9,647 $32,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.39 $5,988 - $8,292	-1,889 Reduced 16.4%	9,628 $37,000
Q2 2021 Sep 13, 2021	BUY	$3.02 - $5.21 $34,781 - $60,003	11,517 New	11,517 $45,000

Others Institutions Holding IMMP

# of Institutions

Shares Held

Call Options Held

157K

Put Options Held

71.7K

View Full List

About IMMUTEP Ltd

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $165M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

More about IMMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Immutep LTD Transaction History